1. Home
  2. CRNX vs APLE Comparison

CRNX vs APLE Comparison

Compare CRNX & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$84.78

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

APLE

Apple Hospitality REIT Inc.

HOLD

Current Price

$16.61

Market Cap

3.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
APLE
Founded
2008
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.8B
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
CRNX
APLE
Price
$84.78
$16.61
Analyst Decision
Strong Buy
Buy
Analyst Count
8
8
Target Price
$76.75
$13.00
AVG Volume (30 Days)
2.6M
2.8M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
7.12%
EPS Growth
N/A
N/A
EPS
N/A
0.40
Revenue
$1,039,000.00
$1,238,622,000.00
Revenue This Year
$720.10
$2.31
Revenue Next Year
$184.67
$2.35
P/E Ratio
N/A
$41.68
Revenue Growth
N/A
18.98
52 Week Low
$30.00
$10.85
52 Week High
$84.80
$17.28

Technical Indicators

Market Signals
Indicator
CRNX
APLE
Relative Strength Index (RSI) 89.98 56.16
Support Level $83.47 $15.99
Resistance Level N/A $17.21
Average True Range (ATR) 0.20 0.38
MACD -1.13 0.06
Stochastic Oscillator 98.98 59.89

Price Performance

Historical Comparison
CRNX
APLE

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About APLE Apple Hospitality REIT Inc.

Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.

Share on Social Networks: